Aelius biotech specialises in the development of models of the mucosal surfaces of the human body. Here are details of Aelius biotech’s latest funding round :
🚀 Launch
2018
🏭 Industry
Biotechnology
🧠Management
Peter Chater (Co-founder), Matt Wilcox (Co-founder) and Jeff Pearson (Co-founder)
💸 Funding & Investors
INVESTMENT (Novembre 2023) | $1.25 million |
INVESTORS (Novembre 2023) | led by North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures. |
🎯 Funding purpose
Meet demand by relocating from the university into laboratories in Newcastle, and expand its five-strong team with the creation of ten new jobs in the next two years.
🌐 Country HQ
UK (Newcastle)